Cardiovascular and Renal Damage in Primary Aldosteronism: Outcomes After Treatment
Open Access
- 1 December 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 23 (12) , 1253-1260
Abstract
Primary aldosteronism (PA) is one of the common forms of curable hypertension. Recent views have suggested that PA is far from being relatively benigKeywords
This publication has 79 references indexed in Scilit:
- Mineralocorticoid Receptors in Myocardial InfarctionHypertension, 2009
- Intrarenal Hemodynamics in Primary Aldosteronism before and after TreatmentThe Journal of Clinical Endocrinology & Metabolism, 2009
- Inappropriate Left Ventricular Mass in Patients With Primary AldosteronismHypertension, 2008
- Mineralocorticoid Receptor Activation and Oxidative StressHypertension, 2007
- Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational studyJournal Of Hypertension, 2007
- Renal Damage in Primary AldosteronismHypertension, 2006
- Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated RatsCirculation, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Changes in Left Ventricular Anatomy and Function in Hypertension and Primary AldosteronismHypertension, 1996
- Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension, 1993